New drug RAP-219 aims to tame manic episodes in bipolar i disorder
NCT ID NCT07046494
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tests an investigational drug called RAP-219 for people with bipolar I disorder who are currently experiencing a manic episode. The goal is to see if RAP-219 can safely reduce manic symptoms compared to a placebo. About 250 participants will take either the drug or a placebo, and doctors will measure changes in mania severity using standard rating scales.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR 1 DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arch Clinical Trials
RECRUITINGSt Louis, Missouri, 63125, United States
Contact
Contact
-
CNRI - San Diego, LLC
WITHDRAWNSan Diego, California, 92123, United States
-
CenExel - Decatur
RECRUITINGDecatur, Georgia, 30030, United States
Contact
Contact
-
CenExel - Gaithersburg
ACTIVE_NOT_RECRUITINGGaithersburg, Maryland, 20877, United States
-
CenExel - Hollywood
RECRUITINGHollywood, Florida, 33024, United States
Contact
Contact
-
Collaborative Neuroscience Research - Los Alamitos
RECRUITINGLos Alamitos, California, 90720, United States
Contact
Contact
-
Community Clinical Research, Inc.
RECRUITINGAustin, Texas, 78754, United States
Contact
Contact
-
HD Research - Memorial Hermann Village
RECRUITINGHouston, Texas, 77043, United States
Contact
Contact
-
Inland Psychiatric Medical Group - Chino
ACTIVE_NOT_RECRUITINGChino, California, 91710, United States
-
NRC Research Institute - Orange
RECRUITINGOrange, California, 92868, United States
Contact
Contact
-
NeuroBehavioral Hospitals of the Palm Beaches - South
RECRUITINGBoynton Beach, Florida, 33426, United States
Contact
Contact
-
Neuroscience Research Institute at Ambrosia
RECRUITINGWest Palm Beach, Florida, 33407, United States
Contact
Contact
-
New Hope Clinical Research
RECRUITINGCharlotte, North Carolina, 28211, United States
Contact
Contact
-
Pillar Clinical Research - Chicago
RECRUITINGChicago, Illinois, 60641, United States
Contact
Contact
-
Pillar Clinical Research - Little Rock
RECRUITINGLittle Rock, Arkansas, 72204, United States
Contact
Contact
-
Pillar Clinical Research - Richardson
ACTIVE_NOT_RECRUITINGRichardson, Texas, 75080, United States
-
Richmond Behavioral Associates
RECRUITINGStaten Island, New York, 10314, United States
Contact
Contact
-
Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site
RECRUITINGMiami Lakes, Florida, 33016, United States
Contact
Contact
-
Synergy Clinical Research Center - San Diego
RECRUITINGLemon Grove, California, 91945, United States
Contact
Contact
-
United Research Institute
RECRUITINGHialeah, Florida, 33012, United States
Contact
Contact
-
Woodland International Research Group
WITHDRAWNLittle Rock, Arkansas, 72211, United States
-
Woodland Research Northwest
RECRUITINGRogers, Arkansas, 72758, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.